glp 1 agonist diabetes GLP-1 receptor agonists in the treatment of type 2 – state-of-the-art GLP-1 Receptor Agonists Show Promise

In the past ten years, a series of Phase III trials showed that the synthetic GLP-1/GIP agonists are effective in lowering blood sugar in type 2 diabetic subjects who were both treatment-nave or on typical first-line therapies such as metformin and insulin

Explore This Issue June 2019 All of these drugs carry a warning regarding the possible association with medullary thyroid cancer (MTC) or multiple endocrine neoplasia syndrome 2 (MEN2)

A meta-analysis of studies does show that people who lose more weight (e.g

Y.ZhangJ.ChengX.HuangW

Prostaglandins from cytosolic phospholipase A2/Cyclooxygenase-1 pathway and mitogen-activated protein kinases regulate gene expression in candida albicans-infected macrophages

Data analysed by two-way repeated measures ANOVA to assess main effect effects of treatment ( b , c , f , g , j , k and m ) and two-way ANOVA, multiple comparison, Bonferroni post hoc test ( h )